NO20055889L - 2-etoksy-3-fenylpropansyrederivater for behandling av fettforstyrrelser - Google Patents

2-etoksy-3-fenylpropansyrederivater for behandling av fettforstyrrelser

Info

Publication number
NO20055889L
NO20055889L NO20055889A NO20055889A NO20055889L NO 20055889 L NO20055889 L NO 20055889L NO 20055889 A NO20055889 A NO 20055889A NO 20055889 A NO20055889 A NO 20055889A NO 20055889 L NO20055889 L NO 20055889L
Authority
NO
Norway
Prior art keywords
ethoxy
treatment
acid derivatives
phenylpropanoic acid
fat disorders
Prior art date
Application number
NO20055889A
Other languages
English (en)
Norwegian (no)
Inventor
Eva-Lotte Lindstedt Alstermark
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20055889L publication Critical patent/NO20055889L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20055889A 2003-06-18 2005-12-12 2-etoksy-3-fenylpropansyrederivater for behandling av fettforstyrrelser NO20055889L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0314078.7A GB0314078D0 (en) 2003-06-18 2003-06-18 Therapeutic agents
PCT/GB2004/002619 WO2004113276A1 (en) 2003-06-18 2004-06-16 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders

Publications (1)

Publication Number Publication Date
NO20055889L true NO20055889L (no) 2006-01-12

Family

ID=27636749

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055889A NO20055889L (no) 2003-06-18 2005-12-12 2-etoksy-3-fenylpropansyrederivater for behandling av fettforstyrrelser

Country Status (23)

Country Link
US (1) US7309720B2 (pt)
EP (1) EP1638926A1 (pt)
JP (1) JP2006527752A (pt)
KR (1) KR20060030043A (pt)
CN (1) CN1835916A (pt)
AR (1) AR044827A1 (pt)
AU (1) AU2004249494B2 (pt)
BR (1) BRPI0411579A (pt)
CA (1) CA2529253A1 (pt)
CO (1) CO5650239A2 (pt)
GB (1) GB0314078D0 (pt)
IL (1) IL172377A0 (pt)
IS (1) IS8225A (pt)
MX (1) MXPA05013717A (pt)
MY (1) MY137679A (pt)
NO (1) NO20055889L (pt)
RU (1) RU2005141067A (pt)
SA (1) SA04250194B1 (pt)
TW (1) TW200502202A (pt)
UA (1) UA81810C2 (pt)
UY (1) UY28368A1 (pt)
WO (1) WO2004113276A1 (pt)
ZA (1) ZA200510254B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101444496B (zh) * 2001-06-12 2011-04-13 维尔斯达医疗公司 用于治疗代谢失调的化合物
SE0104333D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
BR0311932A (pt) 2002-06-20 2005-03-22 Astrazeneca Ab Composto, formulação farmacêutica, método para tratar ou prevenir resistência à insulina, uso de um composto, processo para preparar um composto, e, tratamento combinado

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801992D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
MA26634A1 (fr) * 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues

Also Published As

Publication number Publication date
AU2004249494B2 (en) 2008-03-20
MXPA05013717A (es) 2006-03-08
CA2529253A1 (en) 2004-12-29
AR044827A1 (es) 2005-10-05
CN1835916A (zh) 2006-09-20
WO2004113276A1 (en) 2004-12-29
MY137679A (en) 2009-02-27
GB0314078D0 (en) 2003-07-23
KR20060030043A (ko) 2006-04-07
US20060178432A1 (en) 2006-08-10
US7309720B2 (en) 2007-12-18
RU2005141067A (ru) 2006-07-27
SA04250194B1 (ar) 2008-06-02
BRPI0411579A (pt) 2006-08-08
UY28368A1 (es) 2005-01-31
CO5650239A2 (es) 2006-06-30
AU2004249494A1 (en) 2004-12-29
IS8225A (is) 2006-01-10
IL172377A0 (en) 2009-02-11
EP1638926A1 (en) 2006-03-29
UA81810C2 (uk) 2008-02-11
TW200502202A (en) 2005-01-16
ZA200510254B (en) 2007-04-25
JP2006527752A (ja) 2006-12-07

Similar Documents

Publication Publication Date Title
NO20055496L (no) Pyrazolokinazolinderivater, metoder for deres fremstilling og deres anvendelse som kinaseinhibitorer
NO20081482L (no) Delta- og epsilon-krystallformer for imatinibmesylat
NO20030381L (no) Bicyklopyrazoler som er aktive som kinaseinhibitorer, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder slikeforbindelser
NO20081367L (no) Fenyl- og pyridyl-1,2,4-oksadiazolonderivater med fenylgruppe, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytika
NO20064201L (no) Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
NO20072259L (no) Heteroaryltiazoler og deres anvendelse som P13K-inhibitorer
WO2004072031A3 (en) Phenylacetamides and their use as glucokinase modulators
NO20072784L (no) Pyridenkarboksamidderivater for anvendelse som anticancer midler
NO20055887L (no) Pyrido'2, 1-A-isokinoliderivater som DPP-IV-inhibitorer
NO20066055L (no) Pyridinderivater
NO20070576L (no) Nye hydantionderivater for behandling av obstruktive luftveissykdommer.
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
WO2005005414A3 (en) Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
NO20065260L (no) Tri(cyklo)substituerte amidforbindelser
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
NO20053748L (no) Pyrrolopyridazinderivater.
NO20081369L (no) Fenyl- og pyridinyl-1,2,4-oksadiazolonderivater, fremgangsmate for deres fremstilling og deres anvendelse som farmasoytika
WO2006030439A3 (en) Compositions and methods for inducing hair growth
NO20070570L (no) Forbindelser.
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse
NO20073113L (no) Indenylderivater og anvendelse derav for behandling av neurologiske lidelser
NO20080372L (no) Pyrazolderivater som teraputiske midler
NO20070067L (no) Pyrrolopyridinderivater
NO20081681L (no) N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application